title: Influence of cartilage extracellular matrix molecules on cell phenotype and neocartilage formation.
abstract: Interaction between chondrocytes and the cartilage extracellular matrix (ECM) is essential for maintaining the cartilage's role as a low-friction and load-bearing tissue. In this study, we examined the influence of cartilage zone-specific ECM on human articular chondrocytes (HAC) in two-dimensional and three-dimensional (3D) environments. Two culture systems were used. SYSTEM 1: HAC were cultured on cell-culture plates that had been precoated with the following ECM molecules for 7 days: decorin, biglycan, tenascin C (superficial zone), collagen type II, hyaluronan (HA) (middle and deep zones), and osteopontin (deep zone). Uncoated standard culture plates were used as controls. Expanded cells were examined for phenotypic changes using real-time polymerase chain reaction. In addition, expanded cells were placed into high-density pellet cultures for 14 days. Neocartilage formation was assessed via gene expression and histology evaluations. SYSTEM 2: HAC that were cultured on untreated plates and encapsulated in a 3D alginate scaffold were mixed with one of the zone-specific ECM molecules. Cell viability, gene expression, and histology assessments were conducted on 14-day-old tissues. In HAC monolayer culture, exposure to decorin, HA, and osteopontin increased COL2A1 and aggrecan messenger RNA (mRNA) levels compared with controls. Biglycan up-regulated aggrecan without a significant impact on COL2A1 expression; Tenascin C reduced COL2A1 expression. Neocartilage formed after preculture on tenascin C and collagen type II expressed higher COL2A1 mRNA compared with control pellets. Preculture of HAC on HA decreased both COL2A1 and aggrecan expression levels compared with controls, which was consistent with histology. Reduced proteoglycan 4 (PRG4) mRNA levels were observed in HAC pellets that had been precultured with biglycan and collagen type II. Exposing HAC to HA directly in 3D-alginate culture most effectively induced neocartilage formation, showing increased COL2A1 and aggrecan, and reduced COL1A1 compared with controls. Decorin treatments increased HAC COL2A1 mRNA levels. These data indicate that an appropriate exposure to cartilage-specific ECM proteins could be used to enhance cartilage formation and to even induce the formation of zone-specific phenotypes to improve cartilage regeneration.
authors: 1 Shiley Center for Orthopaedic Research and Education , Scripps Clinic, La Jolla, California.
authors: Shawn P
authors: SP
authors: Grogan
authors: Xian
authors: X
authors: Chen
authors: Sujata
authors: S
authors: Sovani
authors: Noboru
authors: N
authors: Taniguchi
authors: Clifford W
authors: CW
authors: Colwell
authors: Martin K
authors: MK
authors: Lotz
authors: Darryl D
authors: DD
authors: D'Lima
mesh_terms: D000328:Adult; D053674:Aggrecans / Q000378:metabolism; D000464:Alginates / Q000494:pharmacology; D002358:Cartilage, Articular / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D020219:Chondrogenesis / Q000187:drug effects / Q000235:genetics; D024043:Collagen Type II / Q000378:metabolism; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D020723:Glucuronic Acid / Q000494:pharmacology; D006603:Hexuronic Acids / Q000494:pharmacology; D006801:Humans; D008297:Male; D009928:Organ Specificity / Q000187:drug effects / Q000235:genetics; D010641:Phenotype; D011509:Proteoglycans / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D000099158:Proteoglycan 4
chemical_list: D053674:Aggrecans; D000464:Alginates; D024043:Collagen Type II; D016326:Extracellular Matrix Proteins; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D011509:Proteoglycans; D012333:RNA, Messenger; C419197:PRG4 protein, human; D000099158:Proteoglycan 4
references: Arthritis Rheum. 2001 Aug;44(8):1795-9
references: 11508431
references: J Orthop Res. 2005 Mar;23(2):446-53
references: 15734261
references: Tissue Eng Part A. 2012 May;18(9-10):920-33
references: 22097912
references: Tissue Eng Part A. 2012 Sep;18(17-18):1784-92
references: 22536910
references: J R Soc Interface. 2012 Dec 7;9(77):3564-73
references: 22809846
references: J Orthop Res. 1996 Sep;14(5):681-9
references: 8893759
references: Tissue Eng. 2005 Mar-Apr;11(3-4):395-403
references: 15871669
references: J Cell Physiol. 2005 Mar;202(3):731-42
references: 15389573
references: Connect Tissue Res. 1988;18(3):205-22
references: 3219850
references: Arthritis Res Ther. 2003;5(1):R60-73
references: 12716454
references: Microsc Res Tech. 1998 Oct 15;43(2):102-10
references: 9822997
references: J Histochem Cytochem. 1994 Apr;42(4):513-22
references: 8126377
references: Biochim Biophys Acta. 1969 May 6;177(3):492-500
references: 4239606
references: Ann N Y Acad Sci. 2003 May;995:140-50
references: 12814946
references: Birth Defects Res C Embryo Today. 2003 May;69(2):174-96
references: 12955860
references: J Biol Chem. 2003 Aug 22;278(34):32259-65
references: 12801931
references: Mol Biol Cell. 2002 Oct;13(10):3601-13
references: 12388760
references: Biochem J. 1983 Feb 1;209(2):387-400
references: 6405736
references: FEBS Lett. 2000 Sep 1;480(2-3):189-92
references: 11034326
references: Biomaterials. 2009 Sep;30(26):4287-96
references: 19464053
references: J Orthop Res. 1999 Jan;17(1):110-20
references: 10073655
references: J Cell Sci. 1990 Oct;97 ( Pt 2):349-60
references: 2277096
references: J Cell Biol. 2000 Aug 21;150(4):913-20
references: 10953015
references: Ann Rheum Dis. 1978 Apr;37(2):168-74
references: 148244
references: J Bone Joint Surg Br. 2005 Aug;87(8):1143-9
references: 16049255
references: Nat Genet. 2005 Feb;37(2):138-44
references: 15640800
references: J Biol Chem. 2011 Oct 28;286(43):37758-67
references: 21880736
references: Cytogenet Cell Genet. 2000;90(3-4):291-7
references: 11124536
references: Connect Tissue Res. 1988;18(3):223-34
references: 3219851
references: Arthritis Rheum. 2003 May;48(5):1315-25
references: 12746904
references: Histochem J. 1994 Dec;26(12):939-45
references: 7896570
references: J Biomed Mater Res A. 2006 Jun 1;77(3):518-25
references: 16482551
references: Artif Organs. 2009 Jun;33(6):439-47
references: 19473139
references: J Orthop Res. 2003 Jan;21(1):132-8
references: 12507590
references: Tissue Eng Part A. 2010 Jan;16(1):81-90
references: 19624244
references: Cell Tissue Res. 2006 Jan;323(1):127-35
references: 16133144
references: J Bone Joint Surg Br. 1970 Aug;52(3):554-63
references: 4247851
references: Arthritis Rheum. 2004 Sep;50(9):2849-57
references: 15457453
references: J Appl Physiol (1985). 2013 Jun;114(11):1610-8
references: 23449937
references: Tissue Eng. 2005 Jan-Feb;11(1-2):76-89
references: 15738663
references: Tissue Eng Part B Rev. 2012 Dec;18(6):436-44
references: 22741572
references: J Biol Chem. 1998 Sep 4;273(36):23463-8
references: 9722583
references: J Cell Biochem. 2006 Aug 1;98(5):1140-9
references: 16514667
references: Arthritis Res Ther. 2009;11(3):R85
references: 19500336
references: J Cell Biol. 1985 Jul;101(1):53-9
references: 3159736
references: Arthritis Rheum. 2007 Feb;56(2):586-95
references: 17265493
references: Arthritis Rheum. 2009 Aug;60(8):2362-71
references: 19644889
references: J Orthop Sci. 2010 Sep;15(5):666-73
references: 20953929
references: Ann Rheum Dis. 1975 Oct;34(5):468
references: 130841
references: J Biomed Mater Res A. 2009 Aug;90(2):456-64
references: 18546186
references: Calcif Tissue Int. 2000 Sep;67(3):230-40
references: 10954778
references: J Orthop Res. 2004 Nov;22(6):1182-7
references: 15475195
references: Arthritis Rheum. 2000 Jun;43(6):1290-9
references: 10857787
references: J Histochem Cytochem. 2000 Jan;48(1):81-8
references: 10653588
references: Osteoarthritis Cartilage. 1994 Jun;2(2):119-31
references: 11548228
references: Biochem Biophys Res Commun. 1999 Jan 27;254(3):535-41
references: 9920774
references: J Cardiovasc Transl Res. 2010 Oct;3(5):478-86
references: 20632221
references: Tissue Eng. 2006 Sep;12(9):2435-47
references: 16995777
references: Biochem J. 1981 Jun 1;195(3):535-43
references: 7316972
references: Eur Cell Mater. 2006 Nov 30;12:92-101
references: 17136680
references: J Pathol. 2002 Sep;198(1):5-13
references: 12210057
references: Tissue Eng Part A. 2009 Feb;15(2):243-54
references: 19193129
references: Exp Cell Res. 1996 May 25;225(1):55-66
references: 8635517
references: Cells Tissues Organs. 2004;178(3):158-67
references: 15655333
references: J Cell Commun Signal. 2009 Dec;3(3-4):287-310
references: 19838819
references: Osteoarthritis Cartilage. 2001 Feb;9(2):112-8
references: 11237658
references: Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1181-6
references: 19139395
references: Tissue Eng Part A. 2011 Jan;17(1-2):231-42
references: 20695759
references: Cell Mol Life Sci. 2005 Oct;62(19-20):2241-56
references: 16143826
references: Biomaterials. 2003 Nov;24(24):4353-64
references: 12922148
references: J Histochem Cytochem. 1984 Feb;32(2):193-201
references: 6363519
references: Ann Rheum Dis. 1982 Oct;41(5):508-11
references: 7125720
references: Tissue Eng. 2004 Jan-Feb;10(1-2):119-27
references: 15009937
references: J Orthop Res. 1996 May;14(3):424-32
references: 8676256
references: Arch Biochem Biophys. 1994 May 15;311(1):144-52
references: 8185311